Female sex hormone replacement therapy increases serum free 1,25‐dihydroxyvitamin D3: a 1‐year prospective study
Explore this paper's citation graph
Summary
To determine whether changes in the biologically active 1,25‐dihydroxyvitamin D3 may be of importance in this process of post‐menopausal bone resorption, the concentrations in the serum were assessed.
- Type
- article
- Published
- 1999-04-01
- Cited by
- 31
- References
- 33
- OpenAlex
- https://openalex.org/W2010090064
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:22776602
Keywords
Internal medicine, Endocrinology, Norethisterone acetate, Free fraction, Chemistry
References
- LONG-TERM PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS BY ŒSTROGEN
- Influence of the vitamin D-binding protein on the serum concentration of 1,25-dihydroxyvitamin D3. Significance of the free 1,25-dihydroxyvitamin D3 concentration.
- Control of 25-hydroxycholecalciferol metabolism by parathyroid glands.
- Evidence for estrogen receptor-linked calcium transport in the intestine.
- Mechanism of renal calcium conservation with estrogen replacement therapy in women in early postmenopause--a clinical research center study.
- Vitamin D metabolism in osteoporotic women during treatment with estrogen, an anabolic steroid, or calcitonin.
- Evidence of estrogen receptors in normal human osteoblast-like cells.
- Prevention of postmenopausal osteoporosis. A comparative study of exercise, calcium supplementation, and hormone-replacement therapy.
- Direct control by calcium of 25-hydroxycholecalciferol-1-hydroxylase activity in chick kidney mitochondria.
- Measurement of free hormones in blood.
- Effects of estrogen on circulating "free" and total 1,25-dihydroxyvitamin D and on the parathyroid-vitamin D axis in postmenopausal women.
- Free cortisol index: a rapid and simple estimation of free cortisol in human plasma.
- Lack of evidence for estrogen receptors in human and bovine parathyroid tissue.
- Advantages of paper chromatography as a preparative step in the assay of 1,25-dihydroxyvitamin D.
- Free and total thyroxine in serum. Ranges and sex differences for selected normals, patients with thyroid disease, and pregnant women.
- Free 1,25-dihydroxyvitamin D levels in serum from normal subjects, pregnant subjects, and subjects with liver disease.
- Radioimmunoassay of the binding protein for vitamin D and its metabolites in human serum: concentrations in normal subjects and patients with disorders of mineral homeostasis.
- Effects of orchidectomy and different modes of high dose estrogen treatment on circulating "free" and total 1,25-dihydroxyvitamin D in patients with prostatic cancer.
- Mammalian mature osteoclasts as estrogen target cells.
- Transport of vitamin D sterols in human plasma: effect of excess vitamin D, 25 hydroxyvitamin D and 1,25 dihydroxyvitamin D
Cited by
- Low Levels of Serum Vitamin D3 Are Associated with Autoimmune Thyroid Disease in Pre-Menopausal Women
- Pharmacokinetic and Pharmacodynamic Comparison of Two Calcium Supplements in Postmenopausal Women
- Studies on the interaction between the estrogen and vitamin D endocrine system
- Clinical implications of a possible role of vitamin D in multiple sclerosis
- Additive effect of alfacalcidol on bone mineral density of the lumbar spine in Taiwanese postmenopausal women treated with hormone replacement therapy and calcium supplementation: a randomized 2‐year study
- Calciotropic hormones, insulin resistance, and the polycystic ovary syndrome.
- Postmenopausal HRT and tibolone in relation to muscle strength and body composition.
- Muscle strength and tibolone: a randomised, double‐blind, placebo‐controlled trial
- Evaluation of the applicability of HRT as a preservative of muscle strength in women.
- The Effects of Calcitriol Therapy on Serum Interleukin-1, Interleukin-6 and Tumour Necrosis Factor-α Concentrations in Post-menopausal Patients with Osteoporosis
- Interaction between Vitamin D Receptor Genotype and Estrogen Receptor α Genotype Influences Vertebral Fracture Risk
- Vitamin D3 Confers Protection from Autoimmune Encephalomyelitis Only in Female Mice1
- Predictors of serum 25-hydroxyvitamin D concentrations among postmenopausal women: the Women's Health Initiative Calcium plus Vitamin D clinical trial.
- Vitamin D intake and lung cancer risk in the Women's Health Initiative.
- VITAMIN D DEFICIENCY CAUSES MUSCULOSKELETAL HYPERSENSITIVITY: THE ROLE OF NOCICEPTOR HYPERINNERVATION
- 1, 25-Dihydroxycholecalciferol (1,25-(OH)2 D3) levels in osteoporosis
- Bone mass pharmacogenetics and ethnic health implications.
- Vitamin D and oestrogen receptor polymorphisms in developmental dysplasia of the hip and primary protrusio acetabuli – A preliminary study
- Vitamin D-binding protein influences total circulating levels of 1,25-dihydroxyvitamin D3 but does not directly modulate the bioactive levels of the hormone in vivo.
- Effekte der systemischen Cholecystokiningabe bei C57BL/6-Mäusen und Einfluss einer chronischen Vitamin D- und /oder Paroxetinbehandlung auf das Verhalten und die HPA-Ahcse bei C57BL/6- und DBA/2-Mäusen
Related papers
- A randomised comparison of the effects of oral versus transdermal 17β‐oestradiol, each combined with sequential oral norethisterone acetate, on serum lipoprotein levels
- Failure of the combination of sequential oral and transdermal estradiol plus norethisterone acetate to affect plasma homocysteine levels.
- The insulin-like growth factor-I system and hormone replacement therapy.
- Randomized trial of effects of estradiol in combination with either norethisterone acetate or trimegestone on lipids and lipoproteins in postmenopausal women
- Norethisterone acetate in combination with estrogen: effects on the skeleton and other organs. A review.
- In vivo conversion of norethisterone and norethisterone acetate to ethinyl etradiol in postmenopausal women.
- Low dose transdermal estradiol/norethisterone acetate treatment over 2 years does not cause endometrial proliferation in postmenopausal women
- Intranasal continuous combined 17 beta-estradiol/norethisterone therapy improves the lipid profile in healthy postmenopausal women.
- Does low-dose, transdermal, norethisterone acetate reliably cause endometrial transformation in postmenopausal oestrogen-users?
- A randomized, double-blind, multicentre study comparing the clinical effects of two sequential estradiol-progestin combinations containing either desogestrel or norethisterone acetate in climacteric women with estrogen deficiency symptoms.